Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145(1):208–16.
W. H. O. Classification WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Female Genital Tumours: Who Classification of Tumours. (2020) ISBN: 9789283245049
Dall’Asta A, Gizzo S, Musarò A, Quaranta M, Noventa M, Migliavacca C, et al. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence. Inter J Clin Experiment Pathol. 2014;7(11):8136–42.
Kempson RL. Sarcoma and related neoplasms. In: Norris HJ, Heritig AT, Abell MR, editors. The Uterus. Baltimore: Williams and Wilkins; 1973.
Tavassoli FA, Devilee P. WHO classification of tumors: pathology and genetics of tumors of the breast and female genital organs. Inter Agency Res Cancer Press. 2003;4:236–9.
Picerno TM, Wasson MN, Gonzalez Rios A, Matthew JZ, Nicholas PT, Matthew KH, et al. Morcellation and the incidence of occult uterine malignancy: a dual-institution review. Int J Gynecol Cancer. 2016;26(1):149–55.
Stewart EA, Quade BJ, Laughlin-Tommaso SK (2017) Variants of uterine leimyomas (fibroids). http://www.uptodate.com. Accessed August 11, 2024.
Berretta R, Rolla M, Merisio C, Giordano G, Nardelli GB. Uterine smooth muscle tumor of uncertain malignant potential: a three-case report. Int J Gynecol Cancer. 2008;18(5):1121–6.
Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113(3):324–6.
PubMed PubMed Central Google Scholar
Bacanakgil BH, Deveci M, Karabuk E, Soyman Z. Uterine smooth muscle tumor of uncertain malignant potential: clinicopathologic-sonographic characteristics, follow-up and recurrence. World J Oncol. 2017;8(3):76–80.
PubMed PubMed Central Google Scholar
Lin G, Yang LY, Huang YT, Ng KK, Ng SH, Ueng SH, et al. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma/smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging. 2016;43:333–42.
Bhardwaj B, Aruna M, Shreekant D. STUMP—a rare aftermath of fibroid surgery. Ann Short Rep. 2020;3:1059.
Yordanov AD, Tantchev L, Vasileva P, Strashilov S, Vasileva-Slaveva M, Konsoulova A. Uterine smooth muscle tumours of uncertain malignant potential: single-centre experience and review of the literature. Menopausal Rev. 2020;19:30–4.
Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18(6):535–88.
Oliva E. Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol. 2014;33(4):374–84.
Gupta M, Laury AL, Nucci MR, Quade BJ. Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopahological analysis of 22 cases with a proposal for the inclusion of additional histological parameters. Histopathology. 2018;73:284–98.
Rizzo A, Ricci AD, Saponara M, De Leo A, Perrone AM, De Iaco P, et al. Recurrent uterine smooth-muscle tumors of uncertain malignant Potential (STUMP): state of the art. Anticancer Res. 2020;40:1229–38.
Travaglino A, Raffone A, Gencarelli A, Caldarelli C, Granata M, Santoro A, et al. Stanford parameters stratify the risk of recurrence in gynecologic smooth muscle tumors of uncertain malignant potential. J Pathol Microbiol Immunol. 2021;129:283–90.
Duvillard P. Gynecological pathology. Case no 7. Smooth muscle tumor of uncertain malignant uterine (STUMP). Ann Pathol. 2012;32:211–3.
Shapiro A, Ferenczy A, Turcotte R, Bruchim I, Gotlieb WH. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma. Gynecol Oncol. 2004;94(3):818–20.
Comments (0)